Literature DB >> 9878127

Elective orthopedic surgery, a model for the study of cytokine activation and regulation.

M van Deuren1, T B Twickler, M C de Waal Malefyt, H Van Beem, J van der Ven-Jongekrijg, C M Verschueren, J W van der Meer.   

Abstract

Induction and downregulation of cytokine production occurs after contact with various inflammatory stimuli. To elucidate the early events after a physical stressor, we studied these processes in 13 patients undergoing elective total hip replacement surgery. In these patients we followed the plasma concentrations of tumour necrosis factor alpha (TNF), interleukin 1beta (IL-1beta), IL-6 and IL-1 receptor antagonist (IL-1Ra), mRNA for these cytokines in peripheral blood cells (PBCs), and the lipopolysaccharide(LPS)-stimulated ex vivo production of these cytokines in whole blood cultures (WBCs). Plasma TNF and IL-1beta were not affected by the surgical procedure, although IL-1beta mRNA levels in PBCs increased significantly. Plasma IL-6 and IL-1Ra increased from 2 to 3 h post-incision onwards. The LPS-induced ex vivo production in WBCs of TNF, IL-1beta and IL-6 decreased from 2 h post-incision; that of IL-1Ra increased. Downregulation of TNF production was not associated with lower TNF-mRNA suggesting post-transcriptional regulatory processes. In contrast, downregulation of IL-1beta production was associated with significantly lower IL-1beta mRNA, suggesting both post-transcriptional and transcriptional mechanisms. Remarkably, the increase of plasma IL-6 occurred when the IL-6 production ex-vivo in WBCs was maximally downregulated. This suggests that other immunocompetent cells and not PBCs are the source for plasma IL-6 and that the IL-6 production in those other cells might be regulated differentially. Copyright 1998 Academic Press

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878127     DOI: 10.1006/cyto.1998.0367

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.

Authors:  Anna Simon; Heiyoung Park; Ravikanth Maddipati; Adrian A Lobito; Ariel C Bulua; Adrianna J Jackson; Jae Jin Chae; Rachel Ettinger; Heleen D de Koning; Anthony C Cruz; Daniel L Kastner; Hirsh Komarow; Richard M Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Serum interleukin-6 response to elective total hip replacement surgery.

Authors:  M A Minetto; G Oprandi; L Saba; S Mussino; A Aprato; A Massè; A Angeli; P Gallinaro
Journal:  Int Orthop       Date:  2006-03-25       Impact factor: 3.075

3.  Alterations in leukocyte function following surgical trauma: differentiation of distinct reaction types and association with tumor necrosis factor gene polymorphisms.

Authors:  Matthias Majetschak; Ulrich Krehmeier; Liljana Ostroverkh; Brunhilde Blömeke; Michael Schäfer
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  The role of cytokines in inflammatory response after total knee arthroplasty in patients with rheumatoid arthritis.

Authors:  B Lisowska; W Maśliński; P Małdyk; J Zabek; E Baranowska
Journal:  Rheumatol Int       Date:  2007-12-11       Impact factor: 2.631

5.  Acute phase response in patients undergoing lumbar spinal surgery: modulation by perioperative treatment with naproxen and famotidine.

Authors:  M Muñoz; J J García-Vallejo; J M Sempere; R Romero; E Olalla; C Sebastián
Journal:  Eur Spine J       Date:  2003-11-21       Impact factor: 3.134

6.  Does Chronic Corticosteroid Use Increase Risks of Readmission, Thromboembolism, and Revision After THA?

Authors:  Matthew R Boylan; Dean C Perfetti; Randa K Elmallah; Viktor E Krebs; Carl B Paulino; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2015-11-09       Impact factor: 4.176

7.  Elevated levels of numerous cytokines in drainage fluid after primary total hip arthroplasty.

Authors:  Huub J L van der Heide; Peter M van der Kraan; Willard J Rijnberg; Pieter Buma; B Willem Schreurs
Journal:  Int Orthop       Date:  2009-08-21       Impact factor: 3.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.